PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
-2.99%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$1.7B
AUM Growth
+$1.7B
(-23%)
Cap. Flow
-$344M
Cap. Flow
% of AUM
-20.23%
Top 10 Holdings %
Top 10 Hldgs %
66.15%
Holding
139
New
17
Increased
29
Reduced
52
Closed
24
Top Buys
| 1 |
Broadcom
AVGO
|
$32.3M |
| 2 |
Nice
NICE
|
$20M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$19.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$17.9M |
| 5 |
Schlumberger
SLB
|
$12.4M |
Top Sells
| 1 |
Cameco
CCJ
|
$96.7M |
| 2 |
ZTO Express
ZTO
|
$68.6M |
| 3 |
Microchip Technology
MCHP
|
$57.6M |
| 4 |
Pinduoduo
PDD
|
$57M |
| 5 |
Trip.com Group
TCOM
|
$53.3M |
Sector Composition
| 1 | Financials | 19.1% |
| 2 | Technology | 16.24% |
| 3 | Industrials | 13.83% |
| 4 | Communication Services | 13.45% |
| 5 | Energy | 13.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Huazhu Hotels Group
HTHT
$11.3B
| $8.2M | 0.48% | 248,238 -37,915 | -13% | -$1.25M |
|
27
Amer Sports
AS
$21.8B
| $6.99M | 0.41% | 250,000 -50,000 | -17% | -$1.4M |
|
28
Zoetis
ZTS
$69.3B
| $6.52M | 0.38% | 40,000 | – | – |
|
29
Roivant Sciences
ROIV
$8.15B
| $6.25M | 0.37% | 528,031 | – | – |
|
|
CNTA
30
Centessa Pharmaceuticals
CNTA
$2.25B
| $6.2M | 0.36% | 370,278 -59,423 | -14% | -$995K |
|
31
Johnson & Johnson
JNJ
$427B
| $5.2M | 0.31% | 35,942 | – | – |
|
32
PayPal
PYPL
$67.1B
| $5.12M | 0.3% | 60,000 +58,686 | +4,466% | +$5.01M |
|
33
Birkenstock
BIRK
$9.59B
| $5.1M | 0.3% | 90,000 | – | – |
|
34
Vera Therapeutics
VERA
$1.38B
| $5.06M | 0.3% | 119,664 -17,725 | -13% | -$750K |
|
35
Immunovant
IMVT
$2.56B
| $5.01M | 0.29% | 202,323 +10,081 | +5% | +$250K |
|
36
CoStar Group
CSGP
$37.9B
| $5.01M | 0.29% | 70,000 +20,000 | +40% | +$1.43M |
|
37
Recursion Pharmaceuticals
RXRX
$2.04B
| $4.96M | 0.29% | 733,011 +546,929 | +294% | +$3.7M |
|
38
e.l.f. Beauty
ELF
$7.09B
| $4.68M | 0.28% | +37,300 | New | +$4.68M |
|
39
Zymeworks
ZYME
$1.12B
| $4.49M | 0.26% | 306,460 -21,062 | -6% | -$308K |
|
40
Apple
AAPL
$3.45T
| $4.38M | 0.26% | 17,500 -2,500 | -13% | -$626K |
|
41
Apogee Therapeutics
APGE
$2.17B
| $4.33M | 0.25% | 95,646 -12,048 | -11% | -$546K |
|
|
BCYC
42
Bicycle Therapeutics
BCYC
$511M
| $4.33M | 0.25% | 309,059 +36,910 | +14% | +$517K |
|
43
ProQR Therapeutics
PRQR
$237M
| $4.08M | 0.24% | +1,538,247 | New | +$4.08M |
|
44
IDEAYA Biosciences
IDYA
$2.15B
| $3.92M | 0.23% | 152,713 +7,996 | +6% | +$205K |
|
45
Wave Life Sciences
WVE
$1.53B
| $3.86M | 0.23% | 311,992 -149,675 | -32% | -$1.85M |
|
46
Microsoft
MSFT
$3.77T
| $3.79M | 0.22% | 8,989 | – | – |
|
47
Veeva Systems
VEEV
$44B
| $3.6M | 0.21% | 17,119 | – | – |
|
48
Netflix
NFLX
$513B
| $3.22M | 0.19% | 3,618 -803 | -18% | -$716K |
|
49
ADC Therapeutics
ADCT
$345M
| $3.21M | 0.19% | 1,612,556 +168,040 | +12% | +$334K |
|
|
MBX
50
MBX Biosciences, Inc. Common Stock
MBX
$507M
| $2.99M | 0.18% | 162,090 +12,090 | +8% | +$223K |
|